nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ABCB1—peripheral nervous system neoplasm	0.191	1	CbGaD
Glyburide—ABCC3—Vincristine—peripheral nervous system neoplasm	0.0398	0.0652	CbGbCtD
Glyburide—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0397	0.065	CbGbCtD
Glyburide—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0383	0.0627	CbGbCtD
Glyburide—ABCC3—Cisplatin—peripheral nervous system neoplasm	0.0372	0.0608	CbGbCtD
Glyburide—ABCC3—Etoposide—peripheral nervous system neoplasm	0.0365	0.0597	CbGbCtD
Glyburide—ABCB11—Vincristine—peripheral nervous system neoplasm	0.0344	0.0563	CbGbCtD
Glyburide—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0288	0.0471	CbGbCtD
Glyburide—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0266	0.0435	CbGbCtD
Glyburide—ABCC3—Doxorubicin—peripheral nervous system neoplasm	0.0249	0.0407	CbGbCtD
Glyburide—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0245	0.04	CbGbCtD
Glyburide—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0224	0.0367	CbGbCtD
Glyburide—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.0215	0.0352	CbGbCtD
Glyburide—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0181	0.0296	CbGbCtD
Glyburide—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0169	0.0276	CbGbCtD
Glyburide—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0166	0.0271	CbGbCtD
Glyburide—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0164	0.0268	CbGbCtD
Glyburide—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0153	0.025	CbGbCtD
Glyburide—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0153	0.025	CbGbCtD
Glyburide—ABCG2—Etoposide—peripheral nervous system neoplasm	0.015	0.0245	CbGbCtD
Glyburide—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0138	0.0226	CbGbCtD
Glyburide—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0138	0.0226	CbGbCtD
Glyburide—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0132	0.0217	CbGbCtD
Glyburide—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0113	0.0185	CbGbCtD
Glyburide—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0102	0.0167	CbGbCtD
Glyburide—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00958	0.0157	CbGbCtD
Glyburide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00828	0.0136	CbGbCtD
Glyburide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0077	0.0126	CbGbCtD
Glyburide—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0059	0.00966	CbGbCtD
Glyburide—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00567	0.00928	CbGbCtD
Glyburide—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0055	0.00901	CbGbCtD
Glyburide—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00541	0.00885	CbGbCtD
Glyburide—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00369	0.00603	CbGbCtD
Glyburide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00354	0.00579	CbGbCtD
Glyburide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00324	0.0053	CbGbCtD
Glyburide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00221	0.00362	CbGbCtD
Glyburide—Sulpiride—BCHE—peripheral nervous system neoplasm	0.00131	0.803	CrCbGaD
Glyburide—Chlorpropamide—ABCB1—peripheral nervous system neoplasm	0.000321	0.197	CrCbGaD
Glyburide—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000194	0.0013	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000194	0.0013	CcSEcCtD
Glyburide—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000194	0.0013	CcSEcCtD
Glyburide—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000194	0.0013	CcSEcCtD
Glyburide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.0013	CcSEcCtD
Glyburide—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000193	0.0013	CcSEcCtD
Glyburide—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000192	0.00129	CcSEcCtD
Glyburide—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000192	0.00129	CcSEcCtD
Glyburide—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000192	0.00129	CcSEcCtD
Glyburide—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000191	0.00128	CcSEcCtD
Glyburide—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000191	0.00128	CcSEcCtD
Glyburide—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.00019	0.00128	CcSEcCtD
Glyburide—Oedema—Vincristine—peripheral nervous system neoplasm	0.00019	0.00128	CcSEcCtD
Glyburide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00019	0.00127	CcSEcCtD
Glyburide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000189	0.00127	CcSEcCtD
Glyburide—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000188	0.00126	CcSEcCtD
Glyburide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000187	0.00126	CcSEcCtD
Glyburide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000187	0.00126	CcSEcCtD
Glyburide—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000187	0.00125	CcSEcCtD
Glyburide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000186	0.00125	CcSEcCtD
Glyburide—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.00125	CcSEcCtD
Glyburide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000186	0.00125	CcSEcCtD
Glyburide—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000185	0.00124	CcSEcCtD
Glyburide—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.000185	0.00124	CcSEcCtD
Glyburide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000185	0.00124	CcSEcCtD
Glyburide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000185	0.00124	CcSEcCtD
Glyburide—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000185	0.00124	CcSEcCtD
Glyburide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000184	0.00124	CcSEcCtD
Glyburide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000184	0.00124	CcSEcCtD
Glyburide—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000184	0.00123	CcSEcCtD
Glyburide—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.000184	0.00123	CcSEcCtD
Glyburide—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000182	0.00122	CcSEcCtD
Glyburide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000182	0.00122	CcSEcCtD
Glyburide—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.00122	CcSEcCtD
Glyburide—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000181	0.00122	CcSEcCtD
Glyburide—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.00122	CcSEcCtD
Glyburide—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00018	0.00121	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00018	0.00121	CcSEcCtD
Glyburide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00018	0.00121	CcSEcCtD
Glyburide—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000179	0.0012	CcSEcCtD
Glyburide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000178	0.0012	CcSEcCtD
Glyburide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000178	0.0012	CcSEcCtD
Glyburide—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000178	0.00119	CcSEcCtD
Glyburide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000177	0.00119	CcSEcCtD
Glyburide—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.000177	0.00118	CcSEcCtD
Glyburide—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.00118	CcSEcCtD
Glyburide—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.00118	CcSEcCtD
Glyburide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000176	0.00118	CcSEcCtD
Glyburide—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00118	CcSEcCtD
Glyburide—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000176	0.00118	CcSEcCtD
Glyburide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000176	0.00118	CcSEcCtD
Glyburide—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000175	0.00117	CcSEcCtD
Glyburide—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000174	0.00117	CcSEcCtD
Glyburide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000174	0.00117	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000173	0.00116	CcSEcCtD
Glyburide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.00115	CcSEcCtD
Glyburide—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.00115	CcSEcCtD
Glyburide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000171	0.00115	CcSEcCtD
Glyburide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000171	0.00114	CcSEcCtD
Glyburide—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.00114	CcSEcCtD
Glyburide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000169	0.00113	CcSEcCtD
Glyburide—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.00113	CcSEcCtD
Glyburide—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000168	0.00113	CcSEcCtD
Glyburide—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000168	0.00113	CcSEcCtD
Glyburide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000167	0.00112	CcSEcCtD
Glyburide—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.00112	CcSEcCtD
Glyburide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000166	0.00111	CcSEcCtD
Glyburide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000166	0.00111	CcSEcCtD
Glyburide—Rash—Topotecan—peripheral nervous system neoplasm	0.000166	0.00111	CcSEcCtD
Glyburide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000166	0.00111	CcSEcCtD
Glyburide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000165	0.00111	CcSEcCtD
Glyburide—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000165	0.00111	CcSEcCtD
Glyburide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000165	0.00111	CcSEcCtD
Glyburide—Headache—Topotecan—peripheral nervous system neoplasm	0.000165	0.0011	CcSEcCtD
Glyburide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000164	0.0011	CcSEcCtD
Glyburide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000164	0.0011	CcSEcCtD
Glyburide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000164	0.0011	CcSEcCtD
Glyburide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000164	0.0011	CcSEcCtD
Glyburide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000164	0.0011	CcSEcCtD
Glyburide—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000164	0.0011	CcSEcCtD
Glyburide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000164	0.0011	CcSEcCtD
Glyburide—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.0011	CcSEcCtD
Glyburide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000163	0.0011	CcSEcCtD
Glyburide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000163	0.0011	CcSEcCtD
Glyburide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000163	0.00109	CcSEcCtD
Glyburide—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.00109	CcSEcCtD
Glyburide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000163	0.00109	CcSEcCtD
Glyburide—Rash—Melphalan—peripheral nervous system neoplasm	0.000162	0.00109	CcSEcCtD
Glyburide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000162	0.00109	CcSEcCtD
Glyburide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000162	0.00108	CcSEcCtD
Glyburide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00016	0.00108	CcSEcCtD
Glyburide—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000157	0.00106	CcSEcCtD
Glyburide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000157	0.00105	CcSEcCtD
Glyburide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000157	0.00105	CcSEcCtD
Glyburide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000156	0.00105	CcSEcCtD
Glyburide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000156	0.00105	CcSEcCtD
Glyburide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000156	0.00104	CcSEcCtD
Glyburide—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000155	0.00104	CcSEcCtD
Glyburide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000155	0.00104	CcSEcCtD
Glyburide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000155	0.00104	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000153	0.00103	CcSEcCtD
Glyburide—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000153	0.00103	CcSEcCtD
Glyburide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000153	0.00103	CcSEcCtD
Glyburide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000153	0.00103	CcSEcCtD
Glyburide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000151	0.00101	CcSEcCtD
Glyburide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000151	0.00101	CcSEcCtD
Glyburide—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00101	CcSEcCtD
Glyburide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00015	0.00101	CcSEcCtD
Glyburide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00015	0.00101	CcSEcCtD
Glyburide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000149	0.001	CcSEcCtD
Glyburide—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000149	0.001	CcSEcCtD
Glyburide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000147	0.000986	CcSEcCtD
Glyburide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000146	0.000982	CcSEcCtD
Glyburide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000146	0.000978	CcSEcCtD
Glyburide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000977	CcSEcCtD
Glyburide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000145	0.000975	CcSEcCtD
Glyburide—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000969	CcSEcCtD
Glyburide—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000144	0.000967	CcSEcCtD
Glyburide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000142	0.000951	CcSEcCtD
Glyburide—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.00095	CcSEcCtD
Glyburide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00014	0.000941	CcSEcCtD
Glyburide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.000938	CcSEcCtD
Glyburide—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000935	CcSEcCtD
Glyburide—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000931	CcSEcCtD
Glyburide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000139	0.000931	CcSEcCtD
Glyburide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000138	0.000929	CcSEcCtD
Glyburide—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000925	CcSEcCtD
Glyburide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000137	0.000923	CcSEcCtD
Glyburide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000137	0.000917	CcSEcCtD
Glyburide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000135	0.000909	CcSEcCtD
Glyburide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000135	0.000907	CcSEcCtD
Glyburide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000134	0.000902	CcSEcCtD
Glyburide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000134	0.0009	CcSEcCtD
Glyburide—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000896	CcSEcCtD
Glyburide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000133	0.000893	CcSEcCtD
Glyburide—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000887	CcSEcCtD
Glyburide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00013	0.000874	CcSEcCtD
Glyburide—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000862	CcSEcCtD
Glyburide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000127	0.000853	CcSEcCtD
Glyburide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000127	0.000849	CcSEcCtD
Glyburide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000849	CcSEcCtD
Glyburide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000126	0.000846	CcSEcCtD
Glyburide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000126	0.000843	CcSEcCtD
Glyburide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000125	0.000836	CcSEcCtD
Glyburide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.000835	CcSEcCtD
Glyburide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000124	0.000832	CcSEcCtD
Glyburide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.000831	CcSEcCtD
Glyburide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000122	0.000822	CcSEcCtD
Glyburide—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.00082	CcSEcCtD
Glyburide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000122	0.000818	CcSEcCtD
Glyburide—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000816	CcSEcCtD
Glyburide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000121	0.000812	CcSEcCtD
Glyburide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000121	0.00081	CcSEcCtD
Glyburide—Rash—Vincristine—peripheral nervous system neoplasm	0.00012	0.000805	CcSEcCtD
Glyburide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00012	0.000805	CcSEcCtD
Glyburide—Headache—Vincristine—peripheral nervous system neoplasm	0.000119	0.0008	CcSEcCtD
Glyburide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000117	0.000787	CcSEcCtD
Glyburide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000787	CcSEcCtD
Glyburide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000785	CcSEcCtD
Glyburide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000115	0.000773	CcSEcCtD
Glyburide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000763	CcSEcCtD
Glyburide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000114	0.000762	CcSEcCtD
Glyburide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000113	0.000759	CcSEcCtD
Glyburide—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000755	CcSEcCtD
Glyburide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000111	0.000742	CcSEcCtD
Glyburide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000109	0.000732	CcSEcCtD
Glyburide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000728	CcSEcCtD
Glyburide—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000722	CcSEcCtD
Glyburide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000107	0.000718	CcSEcCtD
Glyburide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000712	CcSEcCtD
Glyburide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000712	CcSEcCtD
Glyburide—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000711	CcSEcCtD
Glyburide—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000711	CcSEcCtD
Glyburide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000105	0.000708	CcSEcCtD
Glyburide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000706	CcSEcCtD
Glyburide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.0001	0.000671	CcSEcCtD
Glyburide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	9.98e-05	0.00067	CcSEcCtD
Glyburide—Alopecia—Doxorubicin—peripheral nervous system neoplasm	9.95e-05	0.000668	CcSEcCtD
Glyburide—Vomiting—Etoposide—peripheral nervous system neoplasm	9.8e-05	0.000658	CcSEcCtD
Glyburide—Erythema—Doxorubicin—peripheral nervous system neoplasm	9.8e-05	0.000658	CcSEcCtD
Glyburide—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	9.8e-05	0.000658	CcSEcCtD
Glyburide—Anaemia—Epirubicin—peripheral nervous system neoplasm	9.79e-05	0.000657	CcSEcCtD
Glyburide—Rash—Etoposide—peripheral nervous system neoplasm	9.72e-05	0.000652	CcSEcCtD
Glyburide—Dermatitis—Etoposide—peripheral nervous system neoplasm	9.71e-05	0.000652	CcSEcCtD
Glyburide—Headache—Etoposide—peripheral nervous system neoplasm	9.66e-05	0.000648	CcSEcCtD
Glyburide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	9.48e-05	0.000636	CcSEcCtD
Glyburide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	9.23e-05	0.00062	CcSEcCtD
Glyburide—Convulsion—Epirubicin—peripheral nervous system neoplasm	9.18e-05	0.000616	CcSEcCtD
Glyburide—Nausea—Etoposide—peripheral nervous system neoplasm	9.16e-05	0.000615	CcSEcCtD
Glyburide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	9.06e-05	0.000608	CcSEcCtD
Glyburide—Myalgia—Epirubicin—peripheral nervous system neoplasm	9.02e-05	0.000605	CcSEcCtD
Glyburide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	9.02e-05	0.000605	CcSEcCtD
Glyburide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	8.77e-05	0.000589	CcSEcCtD
Glyburide—Confusional state—Epirubicin—peripheral nervous system neoplasm	8.71e-05	0.000585	CcSEcCtD
Glyburide—Oedema—Epirubicin—peripheral nervous system neoplasm	8.64e-05	0.00058	CcSEcCtD
Glyburide—Shock—Epirubicin—peripheral nervous system neoplasm	8.5e-05	0.000571	CcSEcCtD
Glyburide—Convulsion—Doxorubicin—peripheral nervous system neoplasm	8.49e-05	0.00057	CcSEcCtD
Glyburide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	8.48e-05	0.000569	CcSEcCtD
Glyburide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	8.46e-05	0.000568	CcSEcCtD
Glyburide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	8.36e-05	0.000561	CcSEcCtD
Glyburide—Myalgia—Doxorubicin—peripheral nervous system neoplasm	8.34e-05	0.00056	CcSEcCtD
Glyburide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	8.34e-05	0.00056	CcSEcCtD
Glyburide—Anorexia—Epirubicin—peripheral nervous system neoplasm	8.24e-05	0.000553	CcSEcCtD
Glyburide—Hypotension—Epirubicin—peripheral nervous system neoplasm	8.08e-05	0.000542	CcSEcCtD
Glyburide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	8.06e-05	0.000541	CcSEcCtD
Glyburide—Oedema—Doxorubicin—peripheral nervous system neoplasm	8e-05	0.000537	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	7.87e-05	0.000529	CcSEcCtD
Glyburide—Shock—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000528	CcSEcCtD
Glyburide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	7.84e-05	0.000526	CcSEcCtD
Glyburide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000526	CcSEcCtD
Glyburide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	7.76e-05	0.000521	CcSEcCtD
Glyburide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	7.73e-05	0.000519	CcSEcCtD
Glyburide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	7.71e-05	0.000517	CcSEcCtD
Glyburide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	7.62e-05	0.000512	CcSEcCtD
Glyburide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	7.61e-05	0.000511	CcSEcCtD
Glyburide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	7.51e-05	0.000504	CcSEcCtD
Glyburide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000502	CcSEcCtD
Glyburide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000501	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	7.29e-05	0.000489	CcSEcCtD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.2e-05	0.00151	CbGpPWpGaD
Glyburide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.000482	CcSEcCtD
Glyburide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	7.13e-05	0.000479	CcSEcCtD
Glyburide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	7.12e-05	0.000478	CcSEcCtD
Glyburide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	7.07e-05	0.000474	CcSEcCtD
Glyburide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	7.06e-05	0.00149	CbGpPWpGaD
Glyburide—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	7.05e-05	0.00148	CbGpPWpGaD
Glyburide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	7.04e-05	0.000472	CcSEcCtD
Glyburide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	6.95e-05	0.000467	CcSEcCtD
Glyburide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.000463	CcSEcCtD
Glyburide—Urticaria—Epirubicin—peripheral nervous system neoplasm	6.87e-05	0.000461	CcSEcCtD
Glyburide—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	6.87e-05	0.00144	CbGpPWpGaD
Glyburide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	6.83e-05	0.000459	CcSEcCtD
Glyburide—SLC22A6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.77e-05	0.00142	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.73e-05	0.00142	CbGpPWpGaD
Glyburide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	6.59e-05	0.000442	CcSEcCtD
Glyburide—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.55e-05	0.00138	CbGpPWpGaD
Glyburide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.54e-05	0.000439	CcSEcCtD
Glyburide—ABCC1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.48e-05	0.00136	CbGpPWpGaD
Glyburide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000427	CcSEcCtD
Glyburide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	6.35e-05	0.000426	CcSEcCtD
Glyburide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.32e-05	0.000424	CcSEcCtD
Glyburide—SLCO2B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.21e-05	0.00131	CbGpPWpGaD
Glyburide—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.2e-05	0.000416	CcSEcCtD
Glyburide—ABCC9—Neuronal System—HRAS—peripheral nervous system neoplasm	6.17e-05	0.0013	CbGpPWpGaD
Glyburide—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.11e-05	0.00041	CcSEcCtD
Glyburide—ABCB11—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.05e-05	0.00127	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.92e-05	0.00125	CbGpPWpGaD
Glyburide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.91e-05	0.000397	CcSEcCtD
Glyburide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.89e-05	0.000395	CcSEcCtD
Glyburide—CPT1A—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	5.81e-05	0.00122	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.8e-05	0.00122	CbGpPWpGaD
Glyburide—ABCC8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.77e-05	0.00121	CbGpPWpGaD
Glyburide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.000385	CcSEcCtD
Glyburide—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.7e-05	0.0012	CbGpPWpGaD
Glyburide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.66e-05	0.00038	CcSEcCtD
Glyburide—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	5.54e-05	0.00117	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—GNS—peripheral nervous system neoplasm	5.54e-05	0.00116	CbGpPWpGaD
Glyburide—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.5e-05	0.000369	CcSEcCtD
Glyburide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.47e-05	0.000367	CcSEcCtD
Glyburide—Rash—Epirubicin—peripheral nervous system neoplasm	5.45e-05	0.000366	CcSEcCtD
Glyburide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.000365	CcSEcCtD
Glyburide—CPT1A—Metabolism—ENO2—peripheral nervous system neoplasm	5.43e-05	0.00114	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—ENO2—peripheral nervous system neoplasm	5.43e-05	0.00114	CbGpPWpGaD
Glyburide—Headache—Epirubicin—peripheral nervous system neoplasm	5.41e-05	0.000363	CcSEcCtD
Glyburide—KCNJ11—Metabolism—GNS—peripheral nervous system neoplasm	5.37e-05	0.00113	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—NME1—peripheral nervous system neoplasm	5.31e-05	0.00112	CbGpPWpGaD
Glyburide—SLC15A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.2e-05	0.00109	CbGpPWpGaD
Glyburide—KCNJ1—Neuronal System—HRAS—peripheral nervous system neoplasm	5.17e-05	0.00109	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—NME1—peripheral nervous system neoplasm	5.15e-05	0.00108	CbGpPWpGaD
Glyburide—Nausea—Epirubicin—peripheral nervous system neoplasm	5.13e-05	0.000345	CcSEcCtD
Glyburide—ABCC8—Metabolism—COX2—peripheral nervous system neoplasm	5.11e-05	0.00108	CbGpPWpGaD
Glyburide—SLC22A7—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.1e-05	0.00107	CbGpPWpGaD
Glyburide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.08e-05	0.000341	CcSEcCtD
Glyburide—SLCO1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.05e-05	0.00106	CbGpPWpGaD
Glyburide—Rash—Doxorubicin—peripheral nervous system neoplasm	5.04e-05	0.000338	CcSEcCtD
Glyburide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.04e-05	0.000338	CcSEcCtD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.03e-05	0.00106	CbGpPWpGaD
Glyburide—Headache—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	0.000336	CcSEcCtD
Glyburide—SLCO2B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5e-05	0.00105	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.98e-05	0.00105	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—COX2—peripheral nervous system neoplasm	4.95e-05	0.00104	CbGpPWpGaD
Glyburide—SLCO2B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.9e-05	0.00103	CbGpPWpGaD
Glyburide—SLC15A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.82e-05	0.00101	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.82e-05	0.00101	CbGpPWpGaD
Glyburide—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.75e-05	0.000319	CcSEcCtD
Glyburide—ABCC8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.64e-05	0.000977	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—BCHE—peripheral nervous system neoplasm	4.59e-05	0.000965	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—BCHE—peripheral nervous system neoplasm	4.59e-05	0.000965	CbGpPWpGaD
Glyburide—ABCC8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.56e-05	0.000959	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.55e-05	0.000957	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.54e-05	0.000955	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.38e-05	0.000921	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.38e-05	0.000921	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—GNS—peripheral nervous system neoplasm	4.38e-05	0.000921	CbGpPWpGaD
Glyburide—ABCC3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.37e-05	0.00092	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—TH—peripheral nervous system neoplasm	4.31e-05	0.000907	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—TH—peripheral nervous system neoplasm	4.31e-05	0.000907	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.2e-05	0.000884	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—NME1—peripheral nervous system neoplasm	4.2e-05	0.000883	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—GNS—peripheral nervous system neoplasm	4.2e-05	0.000883	CbGpPWpGaD
Glyburide—SLC15A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.18e-05	0.00088	CbGpPWpGaD
Glyburide—SLC22A7—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.11e-05	0.000864	CbGpPWpGaD
Glyburide—SLC15A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.1e-05	0.000863	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—COX2—peripheral nervous system neoplasm	4.04e-05	0.00085	CbGpPWpGaD
Glyburide—SLC22A7—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.03e-05	0.000848	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—NME1—peripheral nervous system neoplasm	4.02e-05	0.000846	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	4e-05	0.000842	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	3.95e-05	0.000831	CbGpPWpGaD
Glyburide—ABCC1—Disease—GNS—peripheral nervous system neoplasm	3.93e-05	0.000826	CbGpPWpGaD
Glyburide—SLC15A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.88e-05	0.000817	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—COX2—peripheral nervous system neoplasm	3.87e-05	0.000815	CbGpPWpGaD
Glyburide—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.86e-05	0.000812	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	3.84e-05	0.000808	CbGpPWpGaD
Glyburide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	3.82e-05	0.000804	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.81e-05	0.000802	CbGpPWpGaD
Glyburide—SLC15A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.81e-05	0.000801	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.78e-05	0.000795	CbGpPWpGaD
Glyburide—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.66e-05	0.000771	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.65e-05	0.000769	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	3.65e-05	0.000769	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	3.6e-05	0.000758	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.58e-05	0.000753	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—GNAS—peripheral nervous system neoplasm	3.52e-05	0.000741	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—GNAS—peripheral nervous system neoplasm	3.52e-05	0.000741	CbGpPWpGaD
Glyburide—ABCC3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.52e-05	0.000741	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.52e-05	0.00074	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	3.5e-05	0.000737	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.47e-05	0.00073	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.45e-05	0.000727	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—ABCB1—peripheral nervous system neoplasm	3.45e-05	0.000727	CbGpPWpGaD
Glyburide—ABCC3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.45e-05	0.000727	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.43e-05	0.000721	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	3.37e-05	0.000709	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—ENO2—peripheral nervous system neoplasm	3.35e-05	0.000706	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	3.34e-05	0.000702	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	3.3e-05	0.000694	CbGpPWpGaD
Glyburide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	3.29e-05	0.000693	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	3.29e-05	0.000692	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.28e-05	0.00069	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—ENO2—peripheral nervous system neoplasm	3.25e-05	0.000684	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.2e-05	0.000674	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	3.2e-05	0.000673	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	3.15e-05	0.000663	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.08e-05	0.000648	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.06e-05	0.000645	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	3.03e-05	0.000638	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.02e-05	0.000635	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.01e-05	0.000633	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.99e-05	0.00063	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	2.89e-05	0.000609	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.88e-05	0.000606	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—BCHE—peripheral nervous system neoplasm	2.83e-05	0.000596	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.83e-05	0.000595	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	2.82e-05	0.000594	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.79e-05	0.000587	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	2.77e-05	0.000584	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.76e-05	0.00058	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—BCHE—peripheral nervous system neoplasm	2.75e-05	0.000578	CbGpPWpGaD
Glyburide—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	2.75e-05	0.000578	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.74e-05	0.000576	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.71e-05	0.000569	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.7e-05	0.000569	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	2.67e-05	0.000562	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—TH—peripheral nervous system neoplasm	2.66e-05	0.000561	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—ENO2—peripheral nervous system neoplasm	2.65e-05	0.000558	CbGpPWpGaD
Glyburide—ABCC8—Neuronal System—HRAS—peripheral nervous system neoplasm	2.64e-05	0.000556	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.62e-05	0.000552	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—TH—peripheral nervous system neoplasm	2.58e-05	0.000544	CbGpPWpGaD
Glyburide—KCNJ11—Neuronal System—HRAS—peripheral nervous system neoplasm	2.56e-05	0.000539	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—ENO2—peripheral nervous system neoplasm	2.54e-05	0.000535	CbGpPWpGaD
Glyburide—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.47e-05	0.000519	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.43e-05	0.000511	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.38e-05	0.000501	CbGpPWpGaD
Glyburide—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	2.38e-05	0.0005	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—BCHE—peripheral nervous system neoplasm	2.24e-05	0.000471	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.22e-05	0.000466	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.21e-05	0.000466	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—GNAS—peripheral nervous system neoplasm	2.18e-05	0.000458	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.16e-05	0.000455	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—BCHE—peripheral nervous system neoplasm	2.15e-05	0.000452	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.14e-05	0.00045	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—ABCB1—peripheral nervous system neoplasm	2.13e-05	0.000449	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	2.13e-05	0.000449	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—GNAS—peripheral nervous system neoplasm	2.11e-05	0.000444	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—TH—peripheral nervous system neoplasm	2.11e-05	0.000443	CbGpPWpGaD
Glyburide—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.09e-05	0.000439	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—ABCB1—peripheral nervous system neoplasm	2.07e-05	0.000436	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.05e-05	0.000432	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.05e-05	0.000431	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.02e-05	0.000425	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—TH—peripheral nervous system neoplasm	2.02e-05	0.000425	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	1.99e-05	0.000419	CbGpPWpGaD
Glyburide—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	1.98e-05	0.000416	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.97e-05	0.000415	CbGpPWpGaD
Glyburide—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	1.92e-05	0.000403	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.87e-05	0.000394	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.86e-05	0.000392	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.84e-05	0.000388	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.81e-05	0.000382	CbGpPWpGaD
Glyburide—ALB—Metabolism—GNS—peripheral nervous system neoplasm	1.78e-05	0.000376	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.78e-05	0.000375	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	1.76e-05	0.00037	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.75e-05	0.000369	CbGpPWpGaD
Glyburide—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	1.73e-05	0.000364	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—GNAS—peripheral nervous system neoplasm	1.72e-05	0.000362	CbGpPWpGaD
Glyburide—ALB—Metabolism—NME1—peripheral nervous system neoplasm	1.71e-05	0.00036	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—ABCB1—peripheral nervous system neoplasm	1.69e-05	0.000355	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	1.68e-05	0.000354	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.68e-05	0.000353	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—GNAS—peripheral nervous system neoplasm	1.65e-05	0.000347	CbGpPWpGaD
Glyburide—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	1.65e-05	0.000347	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.65e-05	0.000347	CbGpPWpGaD
Glyburide—ALB—Metabolism—COX2—peripheral nervous system neoplasm	1.65e-05	0.000347	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.63e-05	0.000343	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.62e-05	0.00034	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.61e-05	0.000338	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.6e-05	0.000337	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	1.58e-05	0.000333	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.56e-05	0.000329	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.54e-05	0.000323	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.5e-05	0.000316	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.5e-05	0.000315	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.48e-05	0.000312	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.48e-05	0.000311	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.47e-05	0.000309	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.46e-05	0.000307	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.44e-05	0.000304	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.44e-05	0.000302	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.41e-05	0.000297	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.41e-05	0.000296	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.4e-05	0.000295	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.39e-05	0.000293	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.35e-05	0.000284	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.33e-05	0.00028	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.31e-05	0.000276	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	1.29e-05	0.000272	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.29e-05	0.000271	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.27e-05	0.000267	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.2e-05	0.000253	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	1.14e-05	0.000239	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.12e-05	0.000235	CbGpPWpGaD
Glyburide—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	1.08e-05	0.000228	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	1.07e-05	0.000226	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.06e-05	0.000222	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	9.71e-06	0.000204	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	9.64e-06	0.000203	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—AKT1—peripheral nervous system neoplasm	9.5e-06	0.0002	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—AKT1—peripheral nervous system neoplasm	9.5e-06	0.0002	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	9.47e-06	0.000199	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	9.24e-06	0.000194	CbGpPWpGaD
Glyburide—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	9.14e-06	0.000192	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	9.06e-06	0.000191	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	8.92e-06	0.000188	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	8.89e-06	0.000187	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	8.85e-06	0.000186	CbGpPWpGaD
Glyburide—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.72e-06	0.000183	CbGpPWpGaD
Glyburide—ALB—Metabolism—TH—peripheral nervous system neoplasm	8.59e-06	0.000181	CbGpPWpGaD
Glyburide—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	8.47e-06	0.000178	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	8.2e-06	0.000173	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	8.01e-06	0.000168	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.82e-06	0.000165	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	7.71e-06	0.000162	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.64e-06	0.000161	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	7.53e-06	0.000158	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	7.48e-06	0.000157	CbGpPWpGaD
Glyburide—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	7.23e-06	0.000152	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.13e-06	0.00015	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	7.03e-06	0.000148	CbGpPWpGaD
Glyburide—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	7.01e-06	0.000148	CbGpPWpGaD
Glyburide—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	6.88e-06	0.000145	CbGpPWpGaD
Glyburide—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	6.44e-06	0.000136	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	6.3e-06	0.000132	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	6.18e-06	0.00013	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	6.14e-06	0.000129	CbGpPWpGaD
Glyburide—ABCC1—Disease—MYC—peripheral nervous system neoplasm	6e-06	0.000126	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—peripheral nervous system neoplasm	5.87e-06	0.000124	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	5.84e-06	0.000123	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	5.74e-06	0.000121	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—peripheral nervous system neoplasm	5.69e-06	0.00012	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	5.63e-06	0.000119	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	5.53e-06	0.000116	CbGpPWpGaD
Glyburide—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	5.29e-06	0.000111	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.93e-06	0.000104	CbGpPWpGaD
Glyburide—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	4.71e-06	9.92e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.71e-06	9.9e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	4.67e-06	9.82e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	4.64e-06	9.77e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	4.64e-06	9.76e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—peripheral nervous system neoplasm	4.45e-06	9.36e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	4.16e-06	8.76e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.87e-06	8.15e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.79e-06	7.97e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.71e-06	7.82e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	3.49e-06	7.34e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	3.07e-06	6.46e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.89e-06	3.98e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.7e-06	3.58e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.66e-06	3.49e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.55e-06	3.26e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.02e-06	2.15e-05	CbGpPWpGaD
